New York 2025 Session Status: Passed Assembly

A10045 — Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause

Last action — Passed Senate

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the Assembly. Introduced January 30, 2026. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the Senate.

Prognosis

Stalled 26% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Passed Assembly

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

Creates a campaign to raise awareness about hormone replacement therapy for menopause symptoms.

This bill establishes a campaign to inform people about hormone replacement therapy as a treatment option for perimenopause and menopause symptoms. It aims to improve awareness and understanding of this therapy's benefits and uses.

What this means for you
  • Women: This means increased access to information about hormone replacement therapy options for managing menopause symptoms.

Summary

Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause.

Bill Text

Action History

  1. RETURNED TO ASSEMBLY

  2. PASSED SENATE

  3. 3RD READING CAL.1321

  4. SUBSTITUTED FOR S8894

  5. REFERRED TO WOMEN'S ISSUES

  6. DELIVERED TO SENATE

  7. PASSED ASSEMBLY

  8. ORDERED TO THIRD READING RULES CAL.236

  9. RULES REPORT CAL.236

  10. REPORTED

  11. REPORTED REFERRED TO RULES

  12. REPORTED REFERRED TO WAYS AND MEANS

  13. REFERRED TO HEALTH

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does A10045 do?
Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause.
Who sponsors A10045?
A10045 is sponsored by Phara Souffrant Forrest.
What is the current status of A10045?
This bill has passed the Assembly. Introduced January 30, 2026. It now moves to the second chamber.
Where can I track A10045?
Track A10045 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on A10045

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of A10045

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →